• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.25% Nasdaq Up0.65%

    Aegerion Pharmaceuticals, Inc. (AEGR)

    -NasdaqGS
    1.82 Up 0.09(5.20%) May 27, 4:00PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
    Total Revenue 239,887   158,373   48,546  
    Cost of Revenue52,332  14,370  5,019  
    Gross Profit 187,555   144,003   43,527  
    Operating Expenses
    Research Development44,862  37,990  29,792  
    Selling General and Administrative187,879  132,715  76,082  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (45,186) (26,702) (62,347)
    Income from Continuing Operations
    Total Other Income/Expenses Net1,221  (2,093)(211)
    Earnings Before Interest And Taxes(43,965)(28,795)(62,558)
    Interest Expense27,605  9,691  453  
    Income Before Tax(71,570)(38,486)(63,011)
    Income Tax Expense1,769  899  347  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(73,339)(39,385)(63,358)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (73,339) (39,385) (63,358)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (73,339) (39,385) (63,358)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.